Representative Work

Chad Bayne Chad Bayne

Results

All Representative Work

Representative Work

Biossil Inc. in its US$43-million financing round

On April 21, 2026, Biossil Inc. announced its US$43-million financing round co-led by Founders Fund and OpenAI. The financing will be used to support the company’s mission of offering previously failed drugs a chance to advance to approval at a fraction of traditional cost and...

Lead Office: Toronto Date Announced: April 21, 2026 Value: US$43 million

Read more
Representative Work

Flora Fertility in its $5-million Seed financing

On April 7, 2026, Flora Fertility announced it closed a $5-million Seed financing round. The round was led by ManchesterStory, with participation from Slauson & Co, TruStage Ventures and BDC Capital, Marathon Fund and Adara Venture Capital. Flora Fertility is transforming how fertility...

Lead Office: Toronto Date Announced: April 7, 2026 Value: $5 million

Read more
Representative Work

Tulip in its strategic merger with Salesfloor

On March 24, 2026, Tulip announced it had entered a strategic merger with Salesfloor, a customer engagement platform, to form a combined company under the Tulip brand and establishing a global provider of AI-powered, human-centric customer engagement solutions for the retail industry. With this...

Lead Office: Toronto Date Announced: March 24, 2026 Value: --

Read more
Representative Work

Tailscale in its acquisition of Border0

On March 17, 2026, Tailscale announced that it acquired Border0. This acquisition will support Tailscale’s goal of building out its privileged access management capabilities. Tailscale is a Toronto-based software company that provides zero-configuration virtual private networks (VPNs) for...

Lead Office: Toronto Date Announced: March 17, 2026 Value: --

Read more
Representative Work

Shakudo in its US$7-million financing

On February 17, 2026, Shakudo announced that it had completed a US$7-million financing round, led by Wittington Ventures. The financing will assist with the company’s expansion to the United States and launch of new products. Shakudo offers an end-to-end platform designed to help businesses...

Lead Office: Montreal Date Announced: February 17, 2026 Value: US$7 million

Read more
Representative Work

Modem in its closing of US$4.4-million Pre-Seed financing

On February 10, 2026, Modem announced it closed a US$4.4-million Pre-Seed financing round led by Accel, with participation from Inovia Capital and several angel investors. The company plans to utilize the funding to assist developers in shipping faster. Modem is an AI product management...

Lead Office: Toronto Date Announced: February 10, 2026 Value: US$4.4 million

Read more
Representative Work

Neo Financial in its $68.5-million equity financing

On February 3, 2026, Neo Financial announced that it secured $68.5 million in an oversubscribed round led by a syndicate of more than 100 Canadian founders, entrepreneurs and institutional investors, including Alberta Investment Management Corporation (AIMCo), Northleaf Capital Partners, Plaza...

Lead Office: Toronto Date Announced: February 3, 2026 Value: $68.5 million

Read more
Representative Work

Waabi in its US$1-billion financing

On January 28, 2026, Waabi announced that it secured US$1 billion in financing. This marks one of the largest funding rounds in Canadian tech history to date which consisted of a US$750-million Series C financing co-led by Khosla Ventures and G2 Venture Partners and an additional milestone-based...

Lead Office: Toronto Date Announced: January 28, 2026 Value: US$1 Billion

Read more
Representative Work

BioRender in Dimension Capital’s investment at a $900-million valuation

On December 18, 2025, BioRender announced that it facilitated a secondary purchase by Dimension Capital at a $900-million valuation. BioRender is a web-based platform that crafts and shares visually engaging scientific figures for communication and publication purposes. Osler, Hoskin &...

Lead Office: Toronto Date Announced: December 18, 2025 Value: $900 million

Read more
Representative Work

Genesys Capital in Enspire DBS Therapy’s $10.3-million Series B1 financing

On January 13, 2026,  Enspire DBS Therapy, Inc. announced that it raised $10.3 million in a Series B1 financing led by Genesys Capital. It also saw participation from existing investors Cleveland Clinic and JobsOhio Ventures. Genesys Capital invests in and builds companies in the...

Lead Office: Toronto Date Announced: January 13, 2026 Value: $10.3 million

Read more